Georgia will receive the antiviral drug "Remdesivir "in two weeks

2020/11/02-1605337444.jpg
Read: 1223     13:00     14 Ноябрь 2020    

Georgia will receive the drug" Remdesivir", which will be used to treat patients with coronavirus. This was announced by the head of the National center for disease control and public health Amiran Gamkrelidze. "Ramdevpir" is a new antiviral drug in the class of nucleotide analogues. On may 1, 2020, the United States issued a simplified "emergency use permit" for Remdesivir for the treatment of COVID-19 in the United States."

"The agreement with the manufacturer of Remdesivir has been finalized, and this medicine will be available in Georgia in two weeks," Gamkrelidze said.

According to him, "Ramdevpir" cannot be found in pharmacy chains Georgia. Basically, this drug will be prescribed to patients with severe forms of coronavirus in the case of hospital treatment.

The American pharmaceutical company Gilead Sciences says that the antiviral drug "remdesivir" developed by It reduces the recovery period of patients with coronavirus to four days.

At the same time, according to the interim results of the Solidarity clinical study conducted by who in different countries of the world, the drug Remdesivir has almost no effect in the treatment of COVID-19 in hospital settings in terms of reducing mortality. The who recognizes that the results of this study are very unreliable.

The who officially recommended that Georgia use the "Ramdevpir" for the treatment of coronavirus in the end of October.

apsny.ge





Tags:



Georgia will receive the antiviral drug "Remdesivir "in two weeks

2020/11/02-1605337444.jpg
Read: 1224     13:00     14 Ноябрь 2020    

Georgia will receive the drug" Remdesivir", which will be used to treat patients with coronavirus. This was announced by the head of the National center for disease control and public health Amiran Gamkrelidze. "Ramdevpir" is a new antiviral drug in the class of nucleotide analogues. On may 1, 2020, the United States issued a simplified "emergency use permit" for Remdesivir for the treatment of COVID-19 in the United States."

"The agreement with the manufacturer of Remdesivir has been finalized, and this medicine will be available in Georgia in two weeks," Gamkrelidze said.

According to him, "Ramdevpir" cannot be found in pharmacy chains Georgia. Basically, this drug will be prescribed to patients with severe forms of coronavirus in the case of hospital treatment.

The American pharmaceutical company Gilead Sciences says that the antiviral drug "remdesivir" developed by It reduces the recovery period of patients with coronavirus to four days.

At the same time, according to the interim results of the Solidarity clinical study conducted by who in different countries of the world, the drug Remdesivir has almost no effect in the treatment of COVID-19 in hospital settings in terms of reducing mortality. The who recognizes that the results of this study are very unreliable.

The who officially recommended that Georgia use the "Ramdevpir" for the treatment of coronavirus in the end of October.

apsny.ge





Tags: